R&D Hurdles and Treatment Cost: Major Restraints on the...

أضاف وظيفة جديدة Wellness

2025-12-05 12:18:44 - ترجمة -

R&D Hurdles and Treatment Cost: Major Restraints on the Widespread Adoption of Novel Therapies in the Osteoarthritis Market Restraints

Despite robust growth drivers, the Osteoarthritis Market Restraints are defined by two persistent issues: the lack of approved Disease-Modifying Osteoarthritis Drugs (DMOADs) and the high cost and complex regulatory pathway for novel biologics and regenerative treatments. 1. Lack of Curative DMOADs: The single most significant restraint is the absence of a widely approved, curative, or truly...

0 التعليقات 0 المشاركات 24 مشاهدة 0 معاينة